Optimizing the Antibiotic Potency and Metabolic Stability of Pyridomycin Using a Semisynthetic Approach
Journal of Medicinal Chemistry · 12.02.2026 · 69 (3) · 2496-2508
DOI: 10.1021/acs.jmedchem.5c02409 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 27.01.2026. Verfasst von Katherine Valderrama und 21 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, Fr…. Hauptthemen laut MEDLINE: Tuberculosis, Pulmonary, Antitubercular Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Schweizerischer Nationalfonds zur F??rderung der Wissenschaftlichen Forschung, European Commission.
Abstract (Originalsprache)
Pyridomycin is a natural product with potent activity against Mycobacterium tuberculosis (Mtb), acting through direct inhibition of the fatty acid synthesis enzyme InhA. As a direct inhibitor, pyridomycin maintains activity on Mtb strains resistant to the InhA targeting prodrugs isoniazid and ethionamide. Evaluation of the drug-like properties of pyridomycin, however, found it to have poor in vitro metabolic stability, thus limiting its drug development potential. To address this limitation, semisynthetic derivatives were generated by replacing the metabolically labile hydroxypicolinic acid group with alternative (hetero)aromatic moieties, identifying several derivatives with improved in vitro metabolic stability and with comparable or even enhanced antibacterial activity. Pharmacokinetic studies in mice, however, revealed that these gains did not reduce systemic clearance in vivo, and neither pyridomycin nor its derivatives were effective in a murine pulmonary tuberculosis model. Overall, semisynthesis yielded more potent, P450-stable analogs, but the improvements were insufficient to provide measurable in vivo efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur Lille, U1019 - UMR 9017 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille, France.
- Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, ETH Zürich, 8093 Zurich, Switzerland.
- Univ. Toulouse, CNRS, IPBS, 31077 Toulouse, France.
- Unit "Tuberculosis & Mycobacteria", Human Bacterial Diseases Service, Infectious Diseases in Humans, 1050 Brussels, Belgium.
- Faculty of Natural Sciences, Department of Biochemistry, Comenius University in Bratislava, Ilkovičova 6, Mlynská dolina, 842 15 Bratislava, Slovakia.
- Univ. Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France.
ORCID-Profile: Francois-Xavier Cantrelle, Lionel Mourey, Katarína Mikušová, Laurent Maveyraud, Karl-Heinz Altmann, Ruben C Hartkoorn
Förderung
- Agence Nationale de la Recherche
- Schweizerischer Nationalfonds zur F??rderung der Wissenschaftlichen Forschung
- European Commission
- Agent??ra na Podporu V??skumu a V??voja
Zitieren
APA
Valderrama, K., Horlacher, O., Publicola, G., Eisenring, P., Kienle, M., Boarbi, S., Kiass, M., Korduláková, J., Chatagnon, J., Piveteau, C., Leroux, F., Savková, K., Záhorszká, M., Cantrelle, F. X., Lherbet, C., Mourey, L., Mikušová, K., Mathys, V., Aichholz, R., …, & Hartkoorn, R. C. (2026). Optimizing the Antibiotic Potency and Metabolic Stability of Pyridomycin Using a Semisynthetic Approach. Journal of Medicinal Chemistry, 69(3), 2496-2508. https://doi.org/10.1021/acs.jmedchem.5c02409
Vancouver
Valderrama K, Horlacher O, Publicola G, Eisenring P, Kienle M, Boarbi S, et al. Optimizing the Antibiotic Potency and Metabolic Stability of Pyridomycin Using a Semisynthetic Approach. Journal of Medicinal Chemistry. 2026;69(3):2496-2508. doi:10.1021/acs.jmedchem.5c02409
BibTeX
@article{Valderrama2026,
author = {Valderrama, Katherine and Horlacher, Oliver and Publicola, Gabriel and Eisenring, Patrick and Kienle, Maryline and Boarbi, Samira and Kiass, Mehdi and Korduláková, Jana and Chatagnon, Jonathan and Piveteau, Catherine and Leroux, Florence and Savková, Karin and Záhorszká, Monika and Cantrelle, Francois-Xavier and Lherbet, Christian and Mourey, Lionel and Mikušová, Katarína and Mathys, Vanessa and Aichholz, Reiner and Maveyraud, Laurent and Altmann, Karl-Heinz and Hartkoorn, Ruben C},
title = {Optimizing the Antibiotic Potency and Metabolic Stability of Pyridomycin Using a Semisynthetic Approach},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {3},
pages = {2496--2508},
doi = {10.1021/acs.jmedchem.5c02409}
}
EUVIMED